- | Reg./File # 148-79-8 Review of an aerobic soil metabolism study. [Transmittal of review] Pages 9-20 removed, registrant data. MRID 41791201. (PDF, 20 pp, 296K) Attachments | James Breithaupt | Environmental Fate & Ground Water Branch | - |
- | Study 1. Determination of aqueous photolysis rate C14-thiabendazole. Pages 6-22 removed, registrant data. MRID 43328305. (PDF, 22 pp, 223K) | J. Breithaupt | Environmental Fate & Ground Water Branch | - |
- | Study 1. Terrestrial field dissipation for thiabendazole in wheat. Pages 7-59 removed, registrant data. MRID 43187201. (PDF, 59 pp, 285K) | J. Breithaupt | Environmental Fate & Ground Water Branch | - |
- | Study 3. Terrestrial field dissipation for thiabendazole in soybeans. Pages 8-60 removed, registrant data. MRID 43187203. (PDF, 60 pp, 297K) | J. Breithaupt | Environmental Fate & Ground Water Branch | - |
- | Reg./File # : 148-79-8 Review of an accumulation in confined rotational crops... Pages 19-52 removed, registrant data. MRID 43267801. (PDF, 56 pp, 859K) Attachments | Akiva Abramovitch | Environmental Fate & Ground Water Branch | - |
- | STUDY 3. 162-2. STUDY ID 416318. Bioconcentration of 14C-thiabendazole in Bluegill Sunfish. MRID No. 416318 (PDF, 2 pp, 18K) | Akiva Abramovitch | Environmental Fate & Ground Water Branch | 416318 |
- | STUDY 2. 162-2. STUDY ID 41559601. Anaerobic soil metabolism of 14C-thiabendazole. ABC Final Report No. 37640. MRID No. 41559601 (PDF, 3 pp, 29K) | Akiva Abramovitch | Environmental Fate & Ground Water Branch | 41559601 |
06/02/2010 | Review of Triple Pack Dermal Absorption Studies for Maxim Quattro (PDF, 7 pp, 325K) | Jessica Ryman | Risk Assessment Branch IV | - |
04/13/2006 | Review of New Use for Thiabendazole (Mertect 340-F) as a seed treatment on dry peas. DP Barcode: 315436, 322581. MRIDs 43187201, -02, 41791201, 41765301, 43328305, 41170102. (PDF, 28 pp, 1MB) | Keara Moore | Environmental Risk Branch | - |
03/08/2002 | Cancer Reclassification of Thiobendazole. Supplement to the Final Report (TXR# 013840) and the February 26, 2002 Memorandum (TXR# 005023). Tox review 050554. (PDF, 36 pp, 1MB) | William Burnam | Health Effects Division | - |
02/26/2002 | Cancer Reclassification of Thiabendazole. Tox review 050523. (PDF, 2 pp, 37K) | William Burnam | Health Effects Division | - |
02/26/2002 | Thiabendazole (PC Code 060101) - Evaluation of Covance Statistical Analysis of Rat Tumor Data. MRID 45591801. Tox review 050498. (PDF, 11 pp, 283K) Attachments | Sanjivani Diwan | Reregistration Branch HED | - |
08/30/2001 | Product Chemistry Review of Thiabendazole Technical (MK-360). Product ingredient source info on page 1 & 4 not included. Pages 2 removed, claimed confidential by submitter. Pages 5-10 removed, manufacturing process info. DP Barcode D276231. MRID 45356401 (PDF, 10 pp, 251K) | Shyam Mathur | Technical Review Branch | - |
02/24/2000 | Thiabendazole - Report of the Cancer Assessment Review Committee. Tox review 013840. (PDF, 39 pp, 608K) | Sanjivani Diwan | Health Effects Division | - |
11/16/1999 | Thiabendazole - Report of the Cancer Assessment Review Committee. Tox Review No. 013840. (PDF, 35 pp, 560K) Attachments | Sanjivani Diwan | Health Effects Division | - |